ONSEPHF TRIAL--PILOT PHASE
ONSEPHF TRIAL--PILOT PHASE
批准号:
2055188
负责人:
DENNIS H. SULLIVAN
金额:
$10.72万
依托单位国家:
美国
项目类别:
财政年份:
1995
资助国家:
美国
项目状态:
已结题
起止时间:
1995-09-30 至 1998-08-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Up to 65% of elderly patients hospitalized with an acute hip fracture are
protein-energy under nourished at admission or develop serious
nutritional deficits while hospitalized. These undernourished patients
are at increased risk of developing serious in-hospital complications,
the likelihood of developing a complication increasing exponentially in
relation to the severity of the nutritional deficits. Despite these
facts, elderly hip fracture patients rarely receive a complete
nutritional assessment. Consequently, their nutritional deficits are
usually not recognized and only rarely is adequate treatment provided.
Several studies suggest that aggressive nutritional support targeted to
these undernourished patients may be beneficial both in terms of
rectifying their nutritional deficits and improving their clinical
outcomes. However, these findings have not been confirmed. The small size
of the studies and questions about the methodology employed have left
orthopedic surgeons and other health we providers unconvinced as to the
benefits of aggressively monitoring and treating the nutritional deficits
of their elderly hip fracture patients. Given the increasing number of
elderly patients who fracture their hip each year, the prevalence of
protein-energy undernutrition in this population, and the increased risk
of morbidity associated with poor nutrition, the efficacy of nutrition
intervention to improve outcomes needs to be established.
This proposal is being submitted as the second (or pilot study) phase of
a planned series of studies designed to test the efficacy of aggressive
post-operative enteral nutrition support to decrease the rate of
postoperative complications or improve longterm outcomes in specifically
defined subgroups of elderly patients who have sustained a hip fracture
requiring surgery. The methods to be employed have been tested and
refined in a recently completed feasibility study of 16 patients. The
objective of this second phase or pilot study is to establish the
feasibility of conducting a statistically powerful multi-center nutrition
intervention study in this patient population. Specifically, the results
will be utilized for power calculations to estimate the sample size
needed for the main study.
In the pilot study, 60 patients admitted with an acute hip fracture will
be randomized to either a treatment or a control group. All study
subjects will undergo repeat clinical and nutritional assessments during
their hospitalization. Patients randomized to the control group will
receive standard care while the treatment group will receive post-
operative nightly enteral feedings in addition to an appropriate hospital
diet. At study end, the groups will be compared with respect to nutrient
intake, change in nutritional status and both short and long-term
clinical outcomes.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
A novel flow cytometric technique for drug cytotoxicity gives results comparable to colony-forming assays.
一种用于药物细胞毒性的新型流式细胞术技术给出了与集落形成测定相当的结果。
DOI:
10.1002/cyto.10101
发表时间:
2002
期刊:
Cytometry
影响因子:
--
作者:
[Poot,Martin, Silber,JohnR, Rabinovitch,PeterS]
通讯作者:
Rabinovitch,PeterS
Werner syndrome lymphoblastoid cells are sensitive to camptothecin-induced apoptosis in S-phase.
沃纳综合征淋巴母细胞对喜树碱诱导的 S 期细胞凋亡敏感。
DOI:
10.1007/s004390050903
发表时间:
1999
期刊:
Human genetics
影响因子:
5.3
作者:
[Poot,M, Gollahon,KA, Rabinovitch,PS]
通讯作者:
Rabinovitch,PS
Analysis of mitochondria by flow cytometry.
通过流式细胞术分析线粒体。
DOI:
10.1016/s0091-679x(01)64009-3
发表时间:
2001
期刊:
Methods in cell biology
影响因子:
--
作者:
[Poot,M, Pierce,RH]
通讯作者:
Pierce,RH
Apoptotic human lymphocytes have diminished CD4 and CD8 receptor expression.
凋亡的人淋巴细胞 CD4 和 CD8 受体表达减少。
DOI:
10.1006/cimm.1998.1443
发表时间:
1999
期刊:
Cellular immunology
影响因子:
4.3
作者:
[Potter,A, Kim,C, Gollahon,KA, Rabinovitch,PS]
通讯作者:
Rabinovitch,PS
Distinct functions for WRN and TP53 in a shared pathway of cellular response to 1-beta-D-arabinofuranosylcytosine and bleomycin.
WRN 和 TP53 在细胞对 1-β-D-阿拉伯呋喃糖基胞嘧啶和博莱霉素反应的共享途径中具有不同的功能。
DOI:
10.1016/j.yexcr.2004.02.011
发表时间:
2004
期刊:
Experimental cell research
影响因子:
3.7
作者:
[Poot,Martin, Jin,Xiaoyang, Hill,JulianeP, Gollahon,KatherineA, Rabinovitch,PeterS]
通讯作者:
Rabinovitch,PeterS
Physiologic Effects of PRMST and Testosterone
-
批准号:6975625
-
项目类别:
-
资助金额:$0.1万
-
财政年份:2004
-
负责人:DENNIS H. SULLIVAN
-
依托单位:
ONSEPHF TRIAL--PILOT PHASE
-
批准号:2055187
-
项目类别:
-
资助金额:$16.96万
-
财政年份:1995
-
负责人:DENNIS H. SULLIVAN
-
依托单位:
海外基金